Total Payments
$4,871
2022 Payments
$199.11
Companies
31
Transactions
309
Medicare Patients
2,524
Medicare Billing
$282,833
Payment Breakdown by Category
Food & Beverage$4,736 (97.2%)
Education$134.52 (2.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,736 | 300 | 97.2% |
| Education | $134.52 | 9 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $752.31 | 51 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $718.36 | 36 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $711.57 | 54 | $0 (2021) |
| GlaxoSmithKline, LLC. | $477.55 | 40 | $0 (2022) |
| Insmed, Inc. | $408.73 | 19 | $0 (2021) |
| Grifols USA, LLC | $329.59 | 21 | $0 (2021) |
| Genentech USA, Inc. | $172.81 | 15 | $0 (2020) |
| Mylan Specialty L.P. | $149.97 | 8 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $145.54 | 9 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $128.50 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $199.11 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($70.05) |
| 2021 | $843.43 | 44 | Insmed, Inc. ($197.17) |
| 2020 | $656.72 | 36 | Insmed, Inc. ($186.53) |
| 2019 | $977.26 | 64 | Sunovion Pharmaceuticals Inc. ($272.76) |
| 2018 | $997.34 | 68 | Sunovion Pharmaceuticals Inc. ($202.21) |
| 2017 | $1,197 | 86 | AstraZeneca Pharmaceuticals LP ($249.85) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/20/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: RESPIRATORY | ||||||
| 06/22/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 05/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $11.73 | General |
| Category: RESPIRATORY | ||||||
| 04/28/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Inflammation | ||||||
| 04/27/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: RESPIRATORY | ||||||
| 03/31/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Respiratory | ||||||
| 03/29/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Inflammation | ||||||
| 03/24/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PAH | ||||||
| 01/06/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Respiratory | ||||||
| 11/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: RESPIRATORY | ||||||
| 11/02/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Respiratory | ||||||
| 09/29/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Respiratory | ||||||
| 09/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: RESPIRATORY | ||||||
| 09/03/2021 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 08/19/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/24/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $94.71 | General |
| Category: Respiratory | ||||||
| 06/17/2021 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 06/17/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $5.84 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 318 | 444 | $138,522 | $39,287 |
| 2021 | 17 | 916 | 1,264 | $322,984 | $96,107 |
| 2020 | 24 | 1,290 | 1,805 | $453,128 | $147,439 |
Total Patients
2,524
Total Services
3,513
Medicare Billing
$282,833
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 125 | $35,375 | $9,674 | 27.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 29 | 55 | $35,475 | $8,940 | 25.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 78 | 126 | $26,586 | $6,709 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 67 | $16,616 | $6,023 | 36.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 36 | $16,848 | $5,531 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $4,080 | $1,276 | 31.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,542 | $1,133 | 32.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 93 | 151 | $92,178 | $25,329 | 27.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 140 | 249 | $70,467 | $19,550 | 27.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 157 | 265 | $55,915 | $14,503 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 150 | $35,170 | $13,991 | 39.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 43 | $18,588 | $6,375 | 34.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 75 | $11,904 | $4,799 | 40.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $8,396 | $2,786 | 33.2% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 15 | 30 | $7,989 | $2,604 | 32.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 17 | $5,097 | $2,196 | 43.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,542 | $1,144 | 32.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,856 | $941.60 | 33.0% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 52 | 52 | $2,600 | $495.04 | 19.0% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 54 | 54 | $3,186 | $434.40 | 13.6% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 60 | 60 | $2,040 | $421.80 | 20.7% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 38 | 39 | $1,794 | $251.94 | 14.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 15 | 18 | $828.00 | $175.05 | 21.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 12 | 14 | $434.00 | $111.17 | 25.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 142 | 220 | $110,880 | $39,094 | 35.3% |
About Dr. David Harris, M.D
Dr. David Harris, M.D is a Pulmonary Disease healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992783559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Harris, M.D has received a total of $4,871 in payments from pharmaceutical and medical device companies, with $199.11 received in 2022. These payments were reported across 309 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,736).
As a Medicare-enrolled provider, Harris has provided services to 2,524 Medicare beneficiaries, totaling 3,513 services with total Medicare billing of $282,833. Data is available for 3 years (2020–2022), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Evansville, IN
- Active Since 01/04/2006
- Last Updated 03/08/2011
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1992783559
Products in Payments
- SYMBICORT (Drug) $547.84
- OFEV (Drug) $433.07
- Arikayce (Drug) $408.73
- LONHALA MAGNAIR (Drug) $378.96
- TRELEGY ELLIPTA (Drug) $250.67
- Utibron (Drug) $202.21
- Prolastin-C (Biological) $167.43
- Prolastin-C Liquid (Biological) $162.16
- BREO (Drug) $151.83
- Yupelri (Drug) $149.97
- STIOLTO (Drug) $145.60
- XARELTO (Drug) $145.54
- STIOLTO RESPIMAT (Drug) $135.68
- DUPIXENT (Biological) $110.78
- Esbriet (Biological) $90.31
- AVYCAZ (Drug) $89.25
- Kcentra (Biological) $84.43
- Xolair (Biological) $82.50
- BROVANA (Drug) $77.12
- ANORO (Drug) $75.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Evansville
Dr. Victor Chavez, Md, MD
Pulmonary Disease — Payments: $54,982
Pulmonary Disease $54,982
Raghav Gupta, M.d, M.D
Pulmonary Disease — Payments: $10,683
Pulmonary Disease $10,683
Ahmed Jawad, Md, MD
Pulmonary Disease — Payments: $6,207
Pulmonary Disease $6,207
Dr. Matthew Tucker, D.o, D.O
Pulmonary Disease — Payments: $5,846
Pulmonary Disease $5,846
David Ryon, Md, MD
Pulmonary Disease — Payments: $4,661
Pulmonary Disease $4,661
Khawaja Zaki, M.d, M.D
Pulmonary Disease — Payments: $4,461
Pulmonary Disease $4,461